Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

People with alopecia areata are more likely to have other immune-related conditions.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Ichthyosis with confetti is a genetic skin disorder with consistent ectodermal malformations and various KRT10 gene mutations.

The guideline provides recommendations for managing alopecia areata effectively.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Higher doses of glucocorticoids increase the risk of blood clots in asthma patients.

Nutrition affects skin health differently based on age and condition.

Paeonol-loaded gels may help reduce inflammation and skin damage in atopic dermatitis.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Inflammation may play a role in causing androgenetic alopecia.

Scarring folliculitis type of acne inversa is linked to specific symptoms and lifestyle factors like smoking and being overweight.

Microneedles improve drug delivery, patient compliance, and have potential in cancer treatment and skin care.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Vitamin D deficiency is common in adults with muscle and bone pain, especially women.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Intradermal microbotox injections work better and last longer for reducing large facial pores than topical application.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Certain cancer drugs can cause skin issues like rashes and itching.

Understanding hair follicle interactions can help treat male pattern baldness.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Cobalt is important for health but too much or too little can cause health problems, and its environmental buildup is a concern.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.